Search Orphan Drug Designations and Approvals
-
| Generic Name: | nitric oxide |
|---|---|
| Date Designated: | 09/05/2008 |
| Orphan Designation: | Use in combination with a drug delivery device for acute treatment of sickle cell vaso-occlusive crisis (pain crises) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Mallinckrodt Hospital Products IP Unlimited 1425 U.S. 206 Bedminster Township, New Jersey 07921 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
